| |
Securities (Disclosure of Interests) Daily Summaries
|
| |
SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - PRINTED: 07/11/01 PAGE: 1
DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
(GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)
STOCK NAME : AV Concept Hold (00595)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
LEE JEONG KWAN G ORD AV CONCEPT HOLDINGS LTD 2,000,000 020502-010505 0.265 1
STOCK NAME : City Telecom (01137)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
WONG WAI KAY RICKY G ORD CITY TELECOM (HONG KONG) LTD 3,000,000 0.580 1
G ORD CITY TELECOM (HONG KONG) LTD 3,000,000 0.580 0
G ORD CITY TELECOM (HONG KONG) LTD 4,000,000 0.580 0
CHEUNG CHI KIN PAUL G ORD CITY TELECOM (HONG KONG) LTD 3,000,000 0.580 1
G ORD CITY TELECOM (HONG KONG) LTD 3,000,000 0.580 0
G ORD CITY TELECOM (HONG KONG) LTD 4,000,000 0.580 0
FUNG SO MUI G ORD CITY TELECOM (HONG KONG) LTD 500,000 011100-110707 0.580 1
G ORD CITY TELECOM (HONG KONG) LTD 500,000 0.260 1
SIO VENG KUAN G ORD CITY TELECOM (HONG KONG) LTD 500,000 0.580 1
CHONG KIN CHUN G ORD CITY TELECOM (HONG KONG) LTD 500,000 0.580 1
STOCK NAME : HK Pharma (00182)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
HUANG SHUYUN G ORD HONG KONG PHARMACEUTICAL HOLDI- 25,000,000 160500-150510 0.639 1 N8
NGS LIMITED
SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - PRINTED: 07/11/01 PAGE: 2
DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
(GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)
STOCK NAME : HK Pharma (00182)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
HUANG SHUYUN G ORD HONG KONG PHARMACEUTICAL HOLDI- 2,000,000 301000-291010 0.460 1 N8
NGS LIMITED
ZHAO DAKE G ORD HONG KONG PHARMACEUTICAL HOLDI- 27,000,000 160500-150510 0.639 1 N8
NGS LIMITED
SUN HIU LU G ORD HONG KONG PHARMACEUTICAL HOLDI- 27,000,000 160500-150510 0.639 1 N8
NGS LIMITED
CHU KWAN G ORD HONG KONG PHARMACEUTICAL HOLDI- 25,200,000 160500-150510 0.639 1 N8
NGS LTD
G ORD HONG KONG PHARMACEUTICAL HOLDI- 1,000,000 301000-291010 0.460 1 N8
NGS LTD
STOCK NAME : Softbank Inv (00648)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
WONG SIN JUST G ORD SOFTBANK INVESTMENT INTERNATIO- 56,550,000 160801-150811 0.480 0
NAL (STRATEGIC) LIMITED
ORD SOFTBANK INVESTMENT INTERNATIO- 37,700,000 - - 0 N9
NAL (STRATEGIC) LIMITED
STOCK NAME : Yangtzekiang Garment (00294)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
CHAN SUK MAN G ORD YANGTZEKIANG GARMENT MANUFACTU- 1,300,000 011094-311201 2.000 2
RING CO. LTD.
SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - PRINTED: 07/11/01 PAGE: 3
DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
(GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)
STOCK NAME : iRegent Group (00575)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
BOKOR INGRAM DOMINIC G ORD iREGENT GROUP LIMITED 500,000 201001-191005 1.060 10
G ORD iREGENT GROUP LIMITED 1,750,000 120402-110406 0.160 10
***** END OF REPORT *****
NOTES:
N1 Please refer to the Company's announcements of 19 September and
29 October 2001.
N2 Please refer to the Company's announcement of 19 October 2001.
N3 Pursuant to Conditional Cash Offer made on behalf of Lasting Legend
Ltd in respect in respect of shares of Melco International
Development Limited.
N4 Please refer to the Company's announcement of 5 November 2001.
N5 The transaction involved were the transfer of 3,000,000 shares from
Mr Yang Yat Kwei, John to Randburg Limited.
N6 Total Consideration: HK$6.00
N7 Appointed as a director of the Company on 1 September 2001.
N8 The exercise period of the options have been extended pursuant to
the resolutions passed at the special general meeting of Hong
Kong Pharmaceutical Holdings Limited on 1 November 2001.
N9 Rights of 37.7 million of securities was assigned to a third party
on 2 November 2001.
N10 SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES
SUBSTANTIAL SHAREHOLDERS' NOTIFICATIONS REPORT
Stock Name: Manulife Financial Corporation (stock code: 945)
*ISC as at 06/11/01 : 482,296,464
The Securities and Futures Commission has granted Manulife Financial
Corporation ("MFC") a partial exemption from compliance with the
Securities (Disclosure of Interests) Ordinance pursuant to guidelines
published under section 2A of the Ordinance. Under the partial
exemption, MFC is not required to prepare registers, maintain records
or file, and MFC's corporate insiders are not required to file, with
Hong Kong regulatory authorities disclosure of interest reports
pursuant to the Ordinance on the condition that MFC will file with
the SEHK disclosures of interests made in Canada and the U.S. where
it maintains primary listings.
1. Under Canadian law, 10% shareholders of MFC have to file reports
to the Ontario Securities Commission ("OSC"). Reports made by 10%
shareholders, if any, can be found in OSC website www.sedar.com.
MFC has agreed to monitor the OSC Weekly Bulletin and Insider
Early Warning Report Press Releases every two weeks and if any
reports by or concerning 10% shareholders and filed, MFC will
provide a hard copy to the SEHK for inspection by the Hong Kong
public. So far, the SEHK has not received any such reports from
MFC.
2. Under U.S. law, 5% shareholders of MFC have to file reports to
the U.S. Securities and Exchange Commission ("SEC") pursuant to
Schedule 13G/13D of the Securities and Exchange Act 1934 of the
United States. Up-to-date reports made by 5% shareholders, if
any, can be found in SEC website at www.sec.gov. MFC has agreed
to monitor the SEC website every two weeks and if any reports on
5% shareholders are filed, MFC will provide a hard copy to the
SEHK for inspection by the Hong Kong public. So far, the SEHK
has not received any such reports from MFC.
3. Hard copies of filings or reports provided by MFC under paragraphs
1 and 2 above (if any) are available for inspection at the SEHK's
office at 11/F., One International Finance Centre, 1 Harbour View
Street, Central, Hong Kong, and upon request in writing to MFC at
MFC's office at Manulife Plaza, The Lee Gardens, 48th Floor, 33
Hysan Avenue, Causeway Bay, Hong Kong. For enquiries or arrange-
ments regarding inspection at the SEHK please contact the SEHK
SDI Unit (Mr. Chan (2840-3707) or Miss Tsui (2840-3769)).
* ISC refers to the latest Issued Share Capital of the listed company
recorded by the Exchange as at the date of this summaries. It might
not promptly reflect changes caused by share placements, rights
issue, bonus issue, etc. Readers should exercise caution when using
these figures.
N11 SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES
DIRECTORS' AND CHIEF EXECUTIVES' NOTIFICATIONS REPORT
Stock Name: Manulife Financial Corporation (stock code: 945)
*ISC as at 06/11/01 : 482,296,464
The Securities and Futures Commission has granted Manulife Financial
Corporation ("MFC") a partial exemption from compliance with the
Securities (Disclosure of Interests) Ordinance pursuant to guidelines
published under section 2A of the Ordinance. Under the partial
exemption, MFC is not required to prepare registers, maintain records
or file, and MFC's corporate insiders are not required to file, with
Hong Kong regulatory authorities disclosure of interest reports
pursuant to the Ordinance on the condition that MFC will file with
the SEHK disclosures of interests made in Canada and the U.S. where
it maintains primary listings.
1. Under Canadian law, "insiders" including directors of MFC have
to file reports to the Ontario Securities Commission ("OSC")
in Form 55 pursuant to the Ontario Securities Act. No Form 55
filings have been made by MFC today.
2. MFC is presently a "foreign private issuer" under U.S. law. As
such, no directors of MFC are required to make any disclosure of
interests filings under the Securities Exchange Act 1934 of the
United States.
* ISC refers to the latest Issued Share Capital of the listed company
recorded by the Exchange as at the date of this summaries. It
might not promptly reflect changes caused by share placements,
rights issue, bonus issue, etc. Readers should exercise caution
when using these figures.
| |